| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | cytokine binding | 1.57e-05 | 157 | 68 | 6 | GO:0019955 | |
| GeneOntologyMolecularFunction | cytokine receptor activity | 1.99e-05 | 97 | 68 | 5 | GO:0004896 | |
| GeneOntologyMolecularFunction | interleukin-12 receptor binding | 1.14e-04 | 5 | 68 | 2 | GO:0005143 | |
| GeneOntologyMolecularFunction | immune receptor activity | 2.48e-04 | 165 | 68 | 5 | GO:0140375 | |
| GeneOntologyMolecularFunction | non-membrane spanning protein tyrosine kinase activity | 5.16e-04 | 46 | 68 | 3 | GO:0004715 | |
| GeneOntologyMolecularFunction | proteoglycan binding | 7.00e-04 | 51 | 68 | 3 | GO:0043394 | |
| GeneOntologyMolecularFunction | cell adhesion molecule binding | 9.49e-04 | 599 | 68 | 8 | GO:0050839 | |
| GeneOntologyBiologicalProcess | positive regulation of interleukin-17 production | 2.27e-06 | 29 | 67 | 4 | GO:0032740 | |
| GeneOntologyBiologicalProcess | positive regulation of NK T cell activation | 3.87e-06 | 10 | 67 | 3 | GO:0051135 | |
| GeneOntologyBiologicalProcess | regulation of NK T cell activation | 7.06e-06 | 12 | 67 | 3 | GO:0051133 | |
| GeneOntologyBiologicalProcess | positive regulation of natural killer cell proliferation | 7.06e-06 | 12 | 67 | 3 | GO:0032819 | |
| GeneOntologyBiologicalProcess | cell-cell adhesion | TYK2 IL1RAPL1 IL12B HHLA2 KIRREL3 PTPN6 NEO1 HMCN1 TENM3 PTPRM TENM1 IGSF9B ITGA2 IL23R | 7.51e-06 | 1077 | 67 | 14 | GO:0098609 |
| GeneOntologyBiologicalProcess | regulation of natural killer cell proliferation | 1.16e-05 | 14 | 67 | 3 | GO:0032817 | |
| GeneOntologyBiologicalProcess | natural killer cell proliferation | 2.58e-05 | 18 | 67 | 3 | GO:0001787 | |
| GeneOntologyBiologicalProcess | NK T cell activation | 2.58e-05 | 18 | 67 | 3 | GO:0051132 | |
| GeneOntologyBiologicalProcess | regulation of interleukin-17 production | 2.85e-05 | 54 | 67 | 4 | GO:0032660 | |
| GeneOntologyBiologicalProcess | interleukin-17 production | 3.53e-05 | 57 | 67 | 4 | GO:0032620 | |
| GeneOntologyBiologicalProcess | T cell proliferation | 4.09e-05 | 288 | 67 | 7 | GO:0042098 | |
| GeneOntologyBiologicalProcess | lymphocyte proliferation | 4.32e-05 | 398 | 67 | 8 | GO:0046651 | |
| GeneOntologyBiologicalProcess | mononuclear cell proliferation | 4.97e-05 | 406 | 67 | 8 | GO:0032943 | |
| GeneOntologyBiologicalProcess | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules | 5.24e-05 | 63 | 67 | 4 | GO:0007157 | |
| GeneOntologyBiologicalProcess | regulation of lymphocyte proliferation | 5.41e-05 | 301 | 67 | 7 | GO:0050670 | |
| GeneOntologyBiologicalProcess | positive regulation of T-helper 17 type immune response | 5.54e-05 | 23 | 67 | 3 | GO:2000318 | |
| GeneOntologyBiologicalProcess | cellular response to cytokine stimulus | TYK2 IL12B PTPN6 ABCA1 FN1 BTK IL20RA CCR1 CTSK IL23R SOS1 IFNAR2 | 5.82e-05 | 967 | 67 | 12 | GO:0071345 |
| GeneOntologyBiologicalProcess | regulation of mononuclear cell proliferation | 6.00e-05 | 306 | 67 | 7 | GO:0032944 | |
| GeneOntologyBiologicalProcess | cell-cell adhesion via plasma-membrane adhesion molecules | 6.91e-05 | 313 | 67 | 7 | GO:0098742 | |
| GeneOntologyBiologicalProcess | negative regulation of interleukin-10 production | 8.07e-05 | 26 | 67 | 3 | GO:0032693 | |
| GeneOntologyBiologicalProcess | leukocyte proliferation | 9.44e-05 | 445 | 67 | 8 | GO:0070661 | |
| GeneOntologyBiologicalProcess | regulation of leukocyte proliferation | 9.99e-05 | 332 | 67 | 7 | GO:0070663 | |
| GeneOntologyBiologicalProcess | regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | 1.15e-04 | 235 | 67 | 6 | GO:0002822 | |
| GeneOntologyBiologicalProcess | regulation of T cell proliferation | 1.17e-04 | 236 | 67 | 6 | GO:0042129 | |
| GeneOntologyBiologicalProcess | positive regulation of activated T cell proliferation | 1.52e-04 | 32 | 67 | 3 | GO:0042104 | |
| GeneOntologyBiologicalProcess | positive regulation of NK T cell proliferation | 1.55e-04 | 6 | 67 | 2 | GO:0051142 | |
| GeneOntologyBiologicalProcess | positive regulation of myeloid leukocyte differentiation | 1.61e-04 | 84 | 67 | 4 | GO:0002763 | |
| GeneOntologyBiologicalProcess | regulation of adaptive immune response | 1.68e-04 | 252 | 67 | 6 | GO:0002819 | |
| GeneOntologyBiologicalProcess | response to cytokine | TYK2 IL12B PTPN6 ABCA1 FN1 BTK IL20RA CCR1 CTSK IL23R SOS1 IFNAR2 | 1.70e-04 | 1083 | 67 | 12 | GO:0034097 |
| GeneOntologyBiologicalProcess | response to peptide | TYK2 IL12B PTPN6 ABCA1 FN1 BTK IL20RA CCR1 CTSK IL23R SOS1 IFNAR2 | 1.97e-04 | 1100 | 67 | 12 | GO:1901652 |
| GeneOntologyBiologicalProcess | positive regulation of natural killer cell activation | 1.99e-04 | 35 | 67 | 3 | GO:0032816 | |
| GeneOntologyBiologicalProcess | regulation of NK T cell proliferation | 2.16e-04 | 7 | 67 | 2 | GO:0051140 | |
| GeneOntologyBiologicalProcess | positive regulation of lymphocyte proliferation | 2.29e-04 | 170 | 67 | 5 | GO:0050671 | |
| GeneOntologyBiologicalProcess | positive regulation of mononuclear cell proliferation | 2.49e-04 | 173 | 67 | 5 | GO:0032946 | |
| GeneOntologyBiologicalProcess | positive regulation of T-helper 17 cell lineage commitment | 2.87e-04 | 8 | 67 | 2 | GO:2000330 | |
| GeneOntologyBiologicalProcess | synaptic membrane adhesion | 3.43e-04 | 42 | 67 | 3 | GO:0099560 | |
| GeneOntologyBiologicalProcess | homophilic cell adhesion via plasma membrane adhesion molecules | 3.56e-04 | 187 | 67 | 5 | GO:0007156 | |
| GeneOntologyBiologicalProcess | positive regulation of memory T cell differentiation | 3.69e-04 | 9 | 67 | 2 | GO:0043382 | |
| GeneOntologyBiologicalProcess | interleukin-12-mediated signaling pathway | 3.69e-04 | 9 | 67 | 2 | GO:0035722 | |
| GeneOntologyBiologicalProcess | positive regulation of leukocyte proliferation | 3.92e-04 | 191 | 67 | 5 | GO:0070665 | |
| GeneOntologyBiologicalProcess | positive regulation of osteoclast differentiation | 3.94e-04 | 44 | 67 | 3 | GO:0045672 | |
| GeneOntologyBiologicalProcess | NK T cell proliferation | 4.60e-04 | 10 | 67 | 2 | GO:0001866 | |
| GeneOntologyBiologicalProcess | regulation of leukocyte differentiation | 4.76e-04 | 429 | 67 | 7 | GO:1902105 | |
| GeneOntologyBiologicalProcess | regulation of T-helper 17 type immune response | 4.80e-04 | 47 | 67 | 3 | GO:2000316 | |
| GeneOntologyBiologicalProcess | cytokine-mediated signaling pathway | 5.46e-04 | 577 | 67 | 8 | GO:0019221 | |
| GeneOntologyBiologicalProcess | positive regulation of cell adhesion | 5.58e-04 | 579 | 67 | 8 | GO:0045785 | |
| GeneOntologyBiologicalProcess | regulation of T-helper 17 cell lineage commitment | 5.61e-04 | 11 | 67 | 2 | GO:2000328 | |
| GeneOntologyBiologicalProcess | regulation of memory T cell differentiation | 6.72e-04 | 12 | 67 | 2 | GO:0043380 | |
| GeneOntologyBiologicalProcess | negative regulation of humoral immune response mediated by circulating immunoglobulin | 6.72e-04 | 12 | 67 | 2 | GO:0002924 | |
| GeneOntologyBiologicalProcess | regulation of activated T cell proliferation | 7.22e-04 | 54 | 67 | 3 | GO:0046006 | |
| GeneOntologyBiologicalProcess | regulation of receptor signaling pathway via JAK-STAT | 7.34e-04 | 125 | 67 | 4 | GO:0046425 | |
| GeneOntologyBiologicalProcess | positive regulation of T cell proliferation | 7.34e-04 | 125 | 67 | 4 | GO:0042102 | |
| GeneOntologyBiologicalProcess | cellular response to interleukin-12 | 7.92e-04 | 13 | 67 | 2 | GO:0071349 | |
| GeneOntologyBiologicalProcess | memory T cell differentiation | 7.92e-04 | 13 | 67 | 2 | GO:0043379 | |
| GeneOntologyBiologicalProcess | positive regulation of receptor signaling pathway via JAK-STAT | 8.90e-04 | 58 | 67 | 3 | GO:0046427 | |
| GeneOntologyBiologicalProcess | immunological memory formation process | 9.22e-04 | 14 | 67 | 2 | GO:0090715 | |
| GeneOntologyBiologicalProcess | positive regulation of T-helper 17 cell differentiation | 9.22e-04 | 14 | 67 | 2 | GO:2000321 | |
| GeneOntologyBiologicalProcess | regulation of lymphocyte mediated immunity | 9.45e-04 | 232 | 67 | 5 | GO:0002706 | |
| GeneOntologyBiologicalProcess | positive regulation of myeloid cell differentiation | 9.51e-04 | 134 | 67 | 4 | GO:0045639 | |
| GeneOntologyBiologicalProcess | leukocyte differentiation | 9.82e-04 | 789 | 67 | 9 | GO:0002521 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell activation | 1.03e-03 | 61 | 67 | 3 | GO:0032814 | |
| GeneOntologyBiologicalProcess | activation of Janus kinase activity | 1.06e-03 | 15 | 67 | 2 | GO:0042976 | |
| GeneOntologyBiologicalProcess | positive regulation of leukocyte differentiation | 1.14e-03 | 242 | 67 | 5 | GO:1902107 | |
| GeneOntologyBiologicalProcess | positive regulation of hemopoiesis | 1.14e-03 | 242 | 67 | 5 | GO:1903708 | |
| GeneOntologyBiologicalProcess | T-helper 17 type immune response | 1.18e-03 | 64 | 67 | 3 | GO:0072538 | |
| GeneOntologyBiologicalProcess | regulation of receptor signaling pathway via STAT | 1.21e-03 | 143 | 67 | 4 | GO:1904892 | |
| GeneOntologyBiologicalProcess | negative regulation of B cell mediated immunity | 1.21e-03 | 16 | 67 | 2 | GO:0002713 | |
| GeneOntologyBiologicalProcess | positive regulation of granulocyte macrophage colony-stimulating factor production | 1.21e-03 | 16 | 67 | 2 | GO:0032725 | |
| GeneOntologyBiologicalProcess | negative regulation of immunoglobulin mediated immune response | 1.21e-03 | 16 | 67 | 2 | GO:0002890 | |
| GeneOntologyBiologicalProcess | response to interleukin-12 | 1.21e-03 | 16 | 67 | 2 | GO:0070671 | |
| GeneOntologyBiologicalProcess | activated T cell proliferation | 1.24e-03 | 65 | 67 | 3 | GO:0050798 | |
| GeneOntologyBiologicalProcess | positive regulation of receptor signaling pathway via STAT | 1.24e-03 | 65 | 67 | 3 | GO:1904894 | |
| GeneOntologyBiologicalProcess | positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | 1.44e-03 | 150 | 67 | 4 | GO:0002824 | |
| GeneOntologyBiologicalProcess | positive regulation of cell fate commitment | 1.54e-03 | 18 | 67 | 2 | GO:0010455 | |
| GeneOntologyBiologicalProcess | positive regulation of lymphocyte activation | 1.56e-03 | 385 | 67 | 6 | GO:0051251 | |
| GeneOntologyBiologicalProcess | regulation of granulocyte macrophage colony-stimulating factor production | 1.72e-03 | 19 | 67 | 2 | GO:0032645 | |
| GeneOntologyBiologicalProcess | negative regulation of humoral immune response | 1.72e-03 | 19 | 67 | 2 | GO:0002921 | |
| GeneOntologyBiologicalProcess | regulation of lymphocyte differentiation | 1.73e-03 | 266 | 67 | 5 | GO:0045619 | |
| GeneOntologyBiologicalProcess | positive regulation of adaptive immune response | 1.79e-03 | 159 | 67 | 4 | GO:0002821 | |
| GeneOntologyBiologicalProcess | regulation of leukocyte activation | 1.79e-03 | 694 | 67 | 8 | GO:0002694 | |
| GeneOntologyBiologicalProcess | regulation of interleukin-10 production | 1.80e-03 | 74 | 67 | 3 | GO:0032653 | |
| GeneOntologyBiologicalProcess | regulation of hemopoiesis | 1.81e-03 | 540 | 67 | 7 | GO:1903706 | |
| GeneOntologyBiologicalProcess | positive regulation of T-helper 1 type immune response | 1.90e-03 | 20 | 67 | 2 | GO:0002827 | |
| GeneOntologyBiologicalProcess | interleukin-10 production | 2.02e-03 | 77 | 67 | 3 | GO:0032613 | |
| GeneOntologyBiologicalProcess | positive regulation of immune system process | TYK2 IL12B HHLA2 PTPN6 CD101 BTK CCR1 C4BPA ITGA2 IL23R SOS1 | 2.07e-03 | 1242 | 67 | 11 | GO:0002684 |
| GeneOntologyBiologicalProcess | granulocyte macrophage colony-stimulating factor production | 2.10e-03 | 21 | 67 | 2 | GO:0032604 | |
| GeneOntologyBiologicalProcess | terpenoid biosynthetic process | 2.10e-03 | 21 | 67 | 2 | GO:0016114 | |
| GeneOntologyBiologicalProcess | immunological memory process | 2.10e-03 | 21 | 67 | 2 | GO:0090713 | |
| GeneOntologyBiologicalProcess | retinal metabolic process | 2.10e-03 | 21 | 67 | 2 | GO:0042574 | |
| GeneOntologyBiologicalProcess | regulation of B cell mediated immunity | 2.17e-03 | 79 | 67 | 3 | GO:0002712 | |
| GeneOntologyBiologicalProcess | B cell receptor signaling pathway | 2.17e-03 | 79 | 67 | 3 | GO:0050853 | |
| GeneOntologyBiologicalProcess | regulation of immunoglobulin mediated immune response | 2.17e-03 | 79 | 67 | 3 | GO:0002889 | |
| GeneOntologyBiologicalProcess | T-helper 17 cell lineage commitment | 2.30e-03 | 22 | 67 | 2 | GO:0072540 | |
| GeneOntologyBiologicalProcess | regulation of humoral immune response mediated by circulating immunoglobulin | 2.30e-03 | 22 | 67 | 2 | GO:0002923 | |
| GeneOntologyCellularComponent | interleukin-23 receptor complex | 6.05e-05 | 4 | 67 | 2 | GO:0072536 | |
| GeneOntologyCellularComponent | side of membrane | TYK2 IL12B HHLA2 ABCA1 NTM CCR1 ITGA2 CTSK OPCML IL23R MTSS2 | 9.76e-05 | 875 | 67 | 11 | GO:0098552 |
| Domain | - | IL1RAPL1 IL12B HHLA2 FLNC KIRREL3 NEO1 FN1 HMCN1 PTPRM NTM CD101 IL20RA IGSF9B VPREB3 OPCML IL23R IFNAR2 | 1.19e-10 | 663 | 67 | 17 | 2.60.40.10 |
| Domain | Ig-like_fold | IL1RAPL1 IL12B HHLA2 FLNC KIRREL3 NEO1 FN1 HMCN1 PTPRM NTM CD101 IL20RA IGSF9B VPREB3 OPCML IL23R IFNAR2 | 3.12e-10 | 706 | 67 | 17 | IPR013783 |
| Domain | FN3_dom | 5.65e-08 | 209 | 67 | 9 | IPR003961 | |
| Domain | IG_LIKE | IL1RAPL1 IL12B HHLA2 KIRREL3 NEO1 HMCN1 PTPRM NTM CD101 IGSF9B VPREB3 OPCML | 1.54e-07 | 491 | 67 | 12 | PS50835 |
| Domain | Ig-like_dom | IL1RAPL1 IL12B HHLA2 KIRREL3 NEO1 HMCN1 PTPRM NTM CD101 IGSF9B VPREB3 OPCML | 1.99e-07 | 503 | 67 | 12 | IPR007110 |
| Domain | IG | IL1RAPL1 HHLA2 KIRREL3 NEO1 HMCN1 PTPRM NTM CD101 IGSF9B VPREB3 OPCML | 2.77e-07 | 421 | 67 | 11 | SM00409 |
| Domain | Ig_sub | IL1RAPL1 HHLA2 KIRREL3 NEO1 HMCN1 PTPRM NTM CD101 IGSF9B VPREB3 OPCML | 2.77e-07 | 421 | 67 | 11 | IPR003599 |
| Domain | Ig_I-set | 3.87e-07 | 190 | 67 | 8 | IPR013098 | |
| Domain | I-set | 3.87e-07 | 190 | 67 | 8 | PF07679 | |
| Domain | IGc2 | 1.92e-06 | 235 | 67 | 8 | SM00408 | |
| Domain | Ig_sub2 | 1.92e-06 | 235 | 67 | 8 | IPR003598 | |
| Domain | FN3 | 7.10e-06 | 199 | 67 | 7 | PS50853 | |
| Domain | Ig_V-set | 7.10e-06 | 199 | 67 | 7 | IPR013106 | |
| Domain | IGv | 7.26e-06 | 75 | 67 | 5 | SM00406 | |
| Domain | fn3 | 2.50e-05 | 162 | 67 | 6 | PF00041 | |
| Domain | V-set | 5.11e-05 | 184 | 67 | 6 | PF07686 | |
| Domain | FN3 | 5.26e-05 | 185 | 67 | 6 | SM00060 | |
| Domain | Tox-GHH_dom | 7.57e-05 | 4 | 67 | 2 | IPR028916 | |
| Domain | Ten_N | 7.57e-05 | 4 | 67 | 2 | IPR009471 | |
| Domain | Ten_N | 7.57e-05 | 4 | 67 | 2 | PF06484 | |
| Domain | TENEURIN_N | 7.57e-05 | 4 | 67 | 2 | PS51361 | |
| Domain | Tox-GHH | 7.57e-05 | 4 | 67 | 2 | PF15636 | |
| Domain | YD | 1.26e-04 | 5 | 67 | 2 | IPR006530 | |
| Domain | Interfer-bind | 5.60e-04 | 10 | 67 | 2 | PF09294 | |
| Domain | Interferon/interleukin_rcp_dom | 5.60e-04 | 10 | 67 | 2 | IPR015373 | |
| Domain | ig | 5.99e-04 | 190 | 67 | 5 | PF00047 | |
| Domain | Immunoglobulin | 5.99e-04 | 190 | 67 | 5 | IPR013151 | |
| Domain | BAH | 6.83e-04 | 11 | 67 | 2 | SM00439 | |
| Domain | BAH | 6.83e-04 | 11 | 67 | 2 | PF01426 | |
| Domain | BAH | 6.83e-04 | 11 | 67 | 2 | PS51038 | |
| Domain | BAH_dom | 6.83e-04 | 11 | 67 | 2 | IPR001025 | |
| Domain | Tissue_fac | 8.18e-04 | 12 | 67 | 2 | PF01108 | |
| Domain | Tissue_factor | 8.18e-04 | 12 | 67 | 2 | IPR001187 | |
| Domain | NHL | 9.64e-04 | 13 | 67 | 2 | PS51125 | |
| Domain | EGF_1 | 2.21e-03 | 255 | 67 | 5 | PS00022 | |
| Domain | Ig_2 | 2.29e-03 | 73 | 67 | 3 | PF13895 | |
| Domain | EGF-like_CS | 2.45e-03 | 261 | 67 | 5 | IPR013032 | |
| Domain | cEGF | 3.90e-03 | 26 | 67 | 2 | IPR026823 | |
| Domain | cEGF | 3.90e-03 | 26 | 67 | 2 | PF12662 | |
| Domain | LIPASE_SER | 3.90e-03 | 26 | 67 | 2 | PS00120 | |
| Domain | SH2 | 7.24e-03 | 110 | 67 | 3 | SM00252 | |
| Domain | PTPc | 7.38e-03 | 36 | 67 | 2 | SM00194 | |
| Domain | SH2 | 7.43e-03 | 111 | 67 | 3 | PS50001 | |
| Domain | SH2 | 7.61e-03 | 112 | 67 | 3 | IPR000980 | |
| Pathway | KEGG_JAK_STAT_SIGNALING_PATHWAY | 2.21e-06 | 155 | 55 | 7 | M17411 | |
| Pathway | REACTOME_INTERLEUKIN_23_SIGNALING | 3.10e-06 | 8 | 55 | 3 | MM15619 | |
| Pathway | REACTOME_INTERLEUKIN_23_SIGNALING | 4.64e-06 | 9 | 55 | 3 | M27896 | |
| Pathway | KEGG_MEDICUS_REFERENCE_IL12_23_TO_JAK_STAT_SIGNALING_PATHWAY | 6.61e-06 | 10 | 55 | 3 | M47907 | |
| Pathway | WP_TCELL_ACTIVATION_SARSCOV2 | 2.30e-05 | 88 | 55 | 5 | M42580 | |
| Pathway | REACTOME_INTERLEUKIN_12_FAMILY_SIGNALING | 3.04e-05 | 16 | 55 | 3 | MM15127 | |
| Pathway | REACTOME_SIGNALING_BY_INTERLEUKINS | 8.04e-05 | 473 | 55 | 9 | M874 | |
| Pathway | REACTOME_REGULATION_OF_IFNA_IFNB_SIGNALING | 9.42e-05 | 23 | 55 | 3 | MM15634 | |
| Pathway | REACTOME_SIGNALING_BY_INTERLEUKINS | 1.04e-04 | 281 | 55 | 7 | MM15130 | |
| Pathway | PID_LYMPH_ANGIOGENESIS_PATHWAY | 1.22e-04 | 25 | 55 | 3 | M274 | |
| Pathway | REACTOME_REGULATION_OF_IFNA_IFNB_SIGNALING | 1.37e-04 | 26 | 55 | 3 | M982 | |
| Pathway | PID_EPO_PATHWAY | 2.82e-04 | 33 | 55 | 3 | M233 | |
| Pathway | REACTOME_INTERFERON_ALPHA_BETA_SIGNALING | 3.09e-04 | 34 | 55 | 3 | MM15631 | |
| Pathway | REACTOME_INTERLEUKIN_12_SIGNALING | 3.10e-04 | 7 | 55 | 2 | MM17223 | |
| Pathway | PID_IL23_PATHWAY | 3.98e-04 | 37 | 55 | 3 | M196 | |
| Pathway | REACTOME_CYTOKINE_SIGNALING_IN_IMMUNE_SYSTEM | 4.54e-04 | 472 | 55 | 8 | MM14539 | |
| Pathway | REACTOME_SIGNALING_BY_ALK_IN_CANCER | 4.68e-04 | 93 | 55 | 4 | M42521 | |
| Pathway | BIOCARTA_IFNA_PATHWAY | 5.29e-04 | 9 | 55 | 2 | M22056 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CYTOKINE_JAK_STAT_SIGNALING_PATHWAY | 7.10e-04 | 45 | 55 | 3 | M47408 | |
| Pathway | REACTOME_INTERLEUKIN_10_SIGNALING | 7.10e-04 | 45 | 55 | 3 | M27605 | |
| Pathway | WP_IL26_SIGNALING | 8.07e-04 | 47 | 55 | 3 | M48074 | |
| Pathway | REACTOME_CYTOKINE_SIGNALING_IN_IMMUNE_SYSTEM | 8.39e-04 | 789 | 55 | 10 | M1060 | |
| Pathway | REACTOME_INTERLEUKIN_4_AND_INTERLEUKIN_13_SIGNALING | 9.12e-04 | 111 | 55 | 4 | M27609 | |
| Pathway | KEGG_MEDICUS_REFERENCE_IL10_FAMILY_TO_JAK_STAT_SIGNALING_PATHWAY | 1.13e-03 | 13 | 55 | 2 | M47556 | |
| Pathway | REACTOME_REGULATION_OF_KIT_SIGNALING | 1.13e-03 | 13 | 55 | 2 | MM14565 | |
| Pathway | REACTOME_ANTIGEN_ACTIVATES_B_CELL_RECEPTOR_BCR_LEADING_TO_GENERATION_OF_SECOND_MESSENGERS | 1.15e-03 | 53 | 55 | 3 | MM15716 | |
| Pathway | WP_IL4_SIGNALING | 1.21e-03 | 54 | 55 | 3 | M39720 | |
| Pathway | WP_INTERFERON_TYPE_I_SIGNALING | 1.21e-03 | 54 | 55 | 3 | M39435 | |
| Pathway | REACTOME_SYNDECAN_INTERACTIONS | 1.32e-03 | 14 | 55 | 2 | MM14923 | |
| Pathway | REACTOME_INTERLEUKIN_12_FAMILY_SIGNALING | 1.42e-03 | 57 | 55 | 3 | M27381 | |
| Pathway | REACTOME_GRB2_SOS_PROVIDES_LINKAGE_TO_MAPK_SIGNALING_FOR_INTEGRINS | 1.52e-03 | 15 | 55 | 2 | M1262 | |
| Pathway | BIOCARTA_IL3_PATHWAY | 1.52e-03 | 15 | 55 | 2 | MM1412 | |
| Pathway | REACTOME_GRB2_SOS_PROVIDES_LINKAGE_TO_MAPK_SIGNALING_FOR_INTEGRINS | 1.52e-03 | 15 | 55 | 2 | MM14959 | |
| Pathway | BIOCARTA_IL3_PATHWAY | 1.52e-03 | 15 | 55 | 2 | M17681 | |
| Pathway | WP_KIT_RECEPTOR_SIGNALING | 1.57e-03 | 59 | 55 | 3 | M39350 | |
| Pubmed | 2.49e-07 | 7 | 68 | 3 | 12023369 | ||
| Pubmed | 5.95e-07 | 9 | 68 | 3 | 11114383 | ||
| Pubmed | IL-23 modulates CD56+/CD3- NK cell and CD56+/CD3+ NK-like T cell function differentially from IL-12. | 8.49e-07 | 10 | 68 | 3 | 19088061 | |
| Pubmed | Divergent effects of IL-12 and IL-23 on the production of IL-17 by human T cells. | 1.17e-06 | 11 | 68 | 3 | 16482511 | |
| Pubmed | Gene-targeted deletion of OPCML and Neurotrimin in mice does not yield congenital heart defects. | 3.77e-06 | 2 | 68 | 2 | 24616287 | |
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 20875477 | ||
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 24547735 | ||
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 18512797 | ||
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 29454820 | ||
| Pubmed | Meta-analysis of the IL23R and IL12B polymorphisms in multiple sclerosis. | 3.77e-06 | 2 | 68 | 2 | 26000455 | |
| Pubmed | Association analysis of IL-12B and IL-23R polymorphisms in myocardial infarction. | 3.77e-06 | 2 | 68 | 2 | 17901940 | |
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 35086377 | ||
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 23955419 | ||
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 34225581 | ||
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 26472011 | ||
| Pubmed | Investigation of association of the IL12B and IL23R genes with psoriatic arthritis. | 3.77e-06 | 2 | 68 | 2 | 19035472 | |
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 19417080 | ||
| Pubmed | The autoimmune disease-associated IL12B and IL23R polymorphisms in multiple sclerosis. | 3.77e-06 | 2 | 68 | 2 | 18082575 | |
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 7891157 | ||
| Pubmed | IL12B SNPs and copy number variation in IL23R gene associated with susceptibility to leprosy. | 3.77e-06 | 2 | 68 | 2 | 23240095 | |
| Pubmed | IL23R and IL12B genes: susceptibility analysis in rheumatoid arthritis. | 3.77e-06 | 2 | 68 | 2 | 19525409 | |
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 23844553 | ||
| Pubmed | IL23R and IL12B polymorphisms in Spanish IBD patients: no evidence of interaction. | 3.77e-06 | 2 | 68 | 2 | 18383521 | |
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 32763537 | ||
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 28464932 | ||
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 17587057 | ||
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 28376405 | ||
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 18034172 | ||
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 11082042 | ||
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 2884254 | ||
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 12819783 | ||
| Pubmed | 5.83e-06 | 130 | 68 | 5 | 28705898 | ||
| Pubmed | 6.77e-06 | 19 | 68 | 3 | 20953190 | ||
| Pubmed | 1.13e-05 | 3 | 68 | 2 | 18800148 | ||
| Pubmed | Interaction of the c-cbl proto-oncogene product with the Tyk-2 protein tyrosine kinase. | 1.13e-05 | 3 | 68 | 2 | 8780698 | |
| Pubmed | 1.13e-05 | 3 | 68 | 2 | 16272291 | ||
| Pubmed | 1.13e-05 | 3 | 68 | 2 | 11737251 | ||
| Pubmed | 1.13e-05 | 3 | 68 | 2 | 10848816 | ||
| Pubmed | IL12B and IL23R polymorphisms are associated with alopecia areata. | 1.13e-05 | 3 | 68 | 2 | 32355229 | |
| Pubmed | 1.13e-05 | 3 | 68 | 2 | 25015728 | ||
| Pubmed | 1.13e-05 | 3 | 68 | 2 | 18456658 | ||
| Pubmed | 1.13e-05 | 3 | 68 | 2 | 38622665 | ||
| Pubmed | Genetic evidence for involvement of the IL23 pathway in Thai psoriatics. | 1.13e-05 | 3 | 68 | 2 | 19705136 | |
| Pubmed | 1.13e-05 | 3 | 68 | 2 | 7629131 | ||
| Pubmed | 1.13e-05 | 3 | 68 | 2 | 16751425 | ||
| Pubmed | 1.13e-05 | 3 | 68 | 2 | 17993580 | ||
| Pubmed | Quantitative proteomics revealed novel proteins associated with molecular subtypes of breast cancer. | 1.13e-05 | 3 | 68 | 2 | 27498393 | |
| Pubmed | Polymorphisms of the IL12B and IL23R genes are associated with psoriasis. | 1.13e-05 | 3 | 68 | 2 | 18219280 | |
| Pubmed | 1.13e-05 | 3 | 68 | 2 | 23093722 | ||
| Pubmed | 1.13e-05 | 3 | 68 | 2 | 24957500 | ||
| Pubmed | 1.13e-05 | 3 | 68 | 2 | 11313414 | ||
| Pubmed | ITGA2 induces STING expression in pancreatic cancer by inducing DNMT1 degradation. | 1.13e-05 | 3 | 68 | 2 | 36331797 | |
| Pubmed | Variants in the 5q31 cytokine gene cluster are associated with psoriasis. | 1.13e-05 | 3 | 68 | 2 | 18075513 | |
| Pubmed | 1.70e-05 | 162 | 68 | 5 | 25826454 | ||
| Pubmed | 2.25e-05 | 4 | 68 | 2 | 12100475 | ||
| Pubmed | 2.25e-05 | 4 | 68 | 2 | 36193505 | ||
| Pubmed | Role of tyrosine phosphatase SHP-1 in the mechanism of endorepellin angiostatic activity. | 2.25e-05 | 4 | 68 | 2 | 19789387 | |
| Pubmed | Mouse ten-m/Odz is a new family of dimeric type II transmembrane proteins expressed in many tissues. | 2.25e-05 | 4 | 68 | 2 | 10225957 | |
| Pubmed | Interleukin gene polymorphisms and alopecia areata: A systematic review and meta-analysis. | 2.25e-05 | 4 | 68 | 2 | 38394507 | |
| Pubmed | 2.25e-05 | 4 | 68 | 2 | 30470842 | ||
| Pubmed | 2.25e-05 | 4 | 68 | 2 | 34813358 | ||
| Pubmed | 2.25e-05 | 4 | 68 | 2 | 9676579 | ||
| Pubmed | 2.25e-05 | 4 | 68 | 2 | 15114670 | ||
| Pubmed | 2.25e-05 | 4 | 68 | 2 | 15870198 | ||
| Pubmed | 2.25e-05 | 4 | 68 | 2 | 34420811 | ||
| Pubmed | Regulation of virus-induced IL-12 and IL-23 expression in human macrophages. | 2.25e-05 | 4 | 68 | 2 | 12421946 | |
| Pubmed | 2.25e-05 | 4 | 68 | 2 | 15699160 | ||
| Pubmed | All four members of the Ten-m/Odz family of transmembrane proteins form dimers. | 2.25e-05 | 4 | 68 | 2 | 12000766 | |
| Pubmed | Selective contribution of Tyk2 to cell activation by lipopolysaccharide. | 2.25e-05 | 4 | 68 | 2 | 18845149 | |
| Pubmed | 2.25e-05 | 4 | 68 | 2 | 38760017 | ||
| Pubmed | 2.25e-05 | 4 | 68 | 2 | 25371211 | ||
| Pubmed | A dual-strategy expression screen for candidate connectivity labels in the developing thalamus. | 3.14e-05 | 91 | 68 | 4 | 28558017 | |
| Pubmed | 3.75e-05 | 5 | 68 | 2 | 17888176 | ||
| Pubmed | The tyrosine phosphatase PTP1C associates with Vav, Grb2, and mSos1 in hematopoietic cells. | 3.75e-05 | 5 | 68 | 2 | 8632004 | |
| Pubmed | 3.75e-05 | 5 | 68 | 2 | 36672770 | ||
| Pubmed | IL-23 Inhibits Melanoma Development by Augmenting DNA Repair and Modulating T Cell Subpopulations. | 3.75e-05 | 5 | 68 | 2 | 28003381 | |
| Pubmed | 3.75e-05 | 5 | 68 | 2 | 25761673 | ||
| Pubmed | 3.75e-05 | 5 | 68 | 2 | 26786557 | ||
| Pubmed | A genome-wide association study of psoriasis and psoriatic arthritis identifies new disease loci. | 3.75e-05 | 5 | 68 | 2 | 18369459 | |
| Pubmed | 3.75e-05 | 5 | 68 | 2 | 12782676 | ||
| Pubmed | Spatiotemporal expression of IgLON family members in the developing mouse nervous system. | 3.75e-05 | 5 | 68 | 2 | 34599206 | |
| Pubmed | 3.75e-05 | 5 | 68 | 2 | 11493006 | ||
| Pubmed | 5.62e-05 | 6 | 68 | 2 | 10358768 | ||
| Pubmed | 5.62e-05 | 6 | 68 | 2 | 26987707 | ||
| Pubmed | 5.62e-05 | 6 | 68 | 2 | 17236132 | ||
| Pubmed | 5.62e-05 | 6 | 68 | 2 | 8943050 | ||
| Pubmed | 5.62e-05 | 6 | 68 | 2 | 16688182 | ||
| Pubmed | 7.86e-05 | 7 | 68 | 2 | 18523483 | ||
| Pubmed | 7.86e-05 | 7 | 68 | 2 | 10330148 | ||
| Pubmed | TLR9 and STING agonists synergistically induce innate and adaptive type-II IFN. | 7.86e-05 | 7 | 68 | 2 | 25529558 | |
| Pubmed | Cutting edge: the pathogenicity of IFN-γ-producing Th17 cells is independent of T-bet. | 7.86e-05 | 7 | 68 | 2 | 23543757 | |
| Pubmed | 7.86e-05 | 7 | 68 | 2 | 9858678 | ||
| Pubmed | IL-12-polarized Th1 cells produce GM-CSF and induce EAE independent of IL-23. | 7.86e-05 | 7 | 68 | 2 | 26220255 | |
| Pubmed | 7.86e-05 | 7 | 68 | 2 | 8034329 | ||
| Pubmed | 7.86e-05 | 7 | 68 | 2 | 12915301 | ||
| Pubmed | 7.86e-05 | 7 | 68 | 2 | 34614413 | ||
| Pubmed | 1.05e-04 | 8 | 68 | 2 | 18438406 | ||
| Pubmed | 1.05e-04 | 8 | 68 | 2 | 11847210 | ||
| Pubmed | 1.05e-04 | 8 | 68 | 2 | 10331952 | ||
| Pubmed | Diverse genome-wide association studies associate the IL12/IL23 pathway with Crohn Disease. | 1.05e-04 | 8 | 68 | 2 | 19249008 | |
| Interaction | APCS interactions | 8.31e-08 | 33 | 68 | 5 | int:APCS | |
| Cytoband | 11q25 | 7.89e-06 | 26 | 68 | 3 | 11q25 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr11q25 | 1.36e-05 | 31 | 68 | 3 | chr11q25 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr6q23 | 7.53e-04 | 119 | 68 | 3 | chr6q23 | |
| Cytoband | 6q23.3 | 7.97e-04 | 28 | 68 | 2 | 6q23.3 | |
| Cytoband | 1q32 | 2.43e-03 | 49 | 68 | 2 | 1q32 | |
| Cytoband | 2p21 | 3.74e-03 | 61 | 68 | 2 | 2p21 | |
| Cytoband | 19p13.2 | 4.84e-03 | 229 | 68 | 3 | 19p13.2 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 4.26e-10 | 161 | 49 | 9 | 593 | |
| GeneFamily | Immunoglobulin like domain containing | 8.33e-07 | 193 | 49 | 7 | 594 | |
| GeneFamily | I-set domain containing|IgLON cell adhesion molecules | 7.16e-05 | 5 | 49 | 2 | 1052 | |
| GeneFamily | Fibulins | 1.99e-04 | 8 | 49 | 2 | 556 | |
| GeneFamily | Fibronectin type III domain containing | 9.18e-04 | 160 | 49 | 4 | 555 | |
| GeneFamily | Adenosine receptors|V-set domain containing | 9.84e-04 | 163 | 49 | 4 | 590 | |
| GeneFamily | Lipases|Arylacetamide deacetylase family | 1.61e-03 | 22 | 49 | 2 | 464 | |
| GeneFamily | Transient receptor potential cation channels | 2.60e-03 | 28 | 49 | 2 | 249 | |
| GeneFamily | CD molecules|I-set domain containing|Immunoglobulin like domain containing|Interleukin receptors|TIR domain containing | 5.78e-03 | 42 | 49 | 2 | 602 | |
| GeneFamily | Ankyrin repeat domain containing|FERM domain containing | 8.11e-03 | 50 | 49 | 2 | 1293 | |
| Coexpression | GSE32986_CURDLAN_LOWDOSE_VS_GMCSF_AND_CURDLAN_LOWDOSE_STIM_DC_UP | 1.35e-05 | 200 | 68 | 6 | M8625 | |
| Coexpression | ZHU_SKIL_TARGETS_UP | 1.84e-05 | 20 | 68 | 3 | M2273 | |
| CoexpressionAtlas | DevelopingKidney_e14.5 whole kidney - Wnt4 KO_emap-6674_top-relative-expression-ranked_500 | 3.94e-06 | 388 | 68 | 9 | gudmap_developingKidney_e14.5 whole kidney - Wnt4 KO_500 | |
| CoexpressionAtlas | DevelopingKidney_e14.5 whole kidney - Wnt4 KO_emap-6674_top-relative-expression-ranked_1000 | ABCA1 NEO1 FBLN2 HMCN1 NTM PEG3 PKDCC FTO EPB41L3 TBC1D8B PAIP1 | 3.94e-05 | 791 | 68 | 11 | gudmap_developingKidney_e14.5 whole kidney - Wnt4 KO_1000 |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_top-relative-expression-ranked_1000 | FLNC NEO1 FN1 HMCN1 TENM3 NSG1 PEG3 FTO EPB41L3 DENND2B MTSS2 | 4.22e-05 | 797 | 68 | 11 | gudmap_dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_1000 |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitTestis_Sma_k-means-cluster#1_top-relative-expression-ranked_1000 | 4.24e-05 | 199 | 68 | 6 | gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_k1_1000 | |
| CoexpressionAtlas | dev gonad_e12.5_F_SupCellPrec_Sry_top-relative-expression-ranked_1000 | NEO1 HMCN1 TENM3 ICE2 NSG1 PEG3 VPREB3 DENND2B MTSS2 SOS1 IFNAR2 | 4.52e-05 | 803 | 68 | 11 | gudmap_dev gonad_e12.5_F_SupCellPrec_Sry_1000 |
| CoexpressionAtlas | facebase_RNAseq_e14.5_palate_poster_oral_Tgfbr2_WT_2500_K4 | FLNC PTPN6 ABCA1 FBLN2 FN1 HMCN1 TENM3 PTPRM ICE2 NSG1 PEG3 PKDCC EPB41L3 | 6.14e-05 | 1148 | 68 | 13 | facebase_RNAseq_e14.5_palate_poster_oral_Tgfbr2_WT_2500_K4 |
| CoexpressionAtlas | Stromal Cells, Fi.Sk, gp38+ CD140a+, Skin, avg-4 | 7.57e-05 | 437 | 68 | 8 | GSM777046_500 | |
| CoexpressionAtlas | DevelopingKidney_e14.5 whole kidney - Wnt4 KO_emap-6674_k-means-cluster#2_top-relative-expression-ranked_1000 | 9.26e-05 | 142 | 68 | 5 | gudmap_developingKidney_e14.5 whole kidney - Wnt4 KO_1000_k2 | |
| CoexpressionAtlas | DevelopingKidney_e14.5 whole kidney - Wnt4 KO_emap-6674_top-relative-expression-ranked_200 | 1.62e-04 | 160 | 68 | 5 | gudmap_developingKidney_e14.5 whole kidney - Wnt4 KO_200 | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_top-relative-expression-ranked_1000 | 2.12e-04 | 797 | 68 | 10 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_1000 | |
| CoexpressionAtlas | Stromal Cells, Ep.MEChi.Th, CD45- EpCAm+ Ly51- MHCIIhi, Thymus, avg-2 | 2.25e-04 | 384 | 68 | 7 | GSM777041_500 | |
| ToppCell | (2)_Fibroblasts-(20)_Fibro-1|World / Cell class and subclass of bone marrow stroma cells in homeostatis | 1.55e-08 | 188 | 68 | 7 | 409a7b69d02e87084ca955e3fe6c77230dee8861 | |
| ToppCell | PND10-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_B-B-B_prolif|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.70e-07 | 183 | 68 | 6 | 956ff95aef9c5521b6a3ba7ac6df0aad242c1c35 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.76e-07 | 191 | 68 | 6 | 4b50fdd310701251e64e16cd2d07ce03dbfd3e3e | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.76e-07 | 191 | 68 | 6 | 75d2197076a9dfc868e8baf95bd4c5e44f438e3e | |
| ToppCell | COPD-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | 4.91e-07 | 192 | 68 | 6 | 62904f94dfce430456f05066522cbf9bd29f4d7e | |
| ToppCell | nucseq|World / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.06e-07 | 193 | 68 | 6 | 779276e775cb2492e8dd36436295a536084a6415 | |
| ToppCell | PND07-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_B-B-B_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.39e-06 | 150 | 68 | 5 | cc8361bdcaa16ab6a0d6a3684690d709bc42ff3b | |
| ToppCell | facs-Skin-Telogen-3m-Epithelial-inner_bulge|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.11e-06 | 156 | 68 | 5 | ba9dfee9373d657d2a55572b41fc62001ad8b037 | |
| ToppCell | facs-Lung-ENDOMUCIN-18m-Myeloid-neutrophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.37e-06 | 158 | 68 | 5 | d43b335e6aa12d84a75b988fbd6127ff1f4af25c | |
| ToppCell | facs-Lung-ENDOMUCIN-18m-Myeloid-Neutrophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.37e-06 | 158 | 68 | 5 | ab12b29ce51ca2fcac469cc932391217d97145f9 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex_-18m-Lymphocytic-T_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.65e-06 | 160 | 68 | 5 | 94e4f5fc2156dd8163811c3b8b0781ea9b3f2e06 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.79e-06 | 161 | 68 | 5 | 1b805f77790aeb8a71b08bfac2fe2eed7343258f | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Neural-neural_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.94e-06 | 162 | 68 | 5 | d28b2ea1d2c8f3c6a107991573471b6d0c49c4ae | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Neural-neural_cell-Schwann_Cell_/_Neural-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.94e-06 | 162 | 68 | 5 | 5bbd7130d4dad9035e73a439dda568195c136f31 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Neural-neural_cell-Schwann_Cell_/_Neural|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.94e-06 | 162 | 68 | 5 | eed223e61c8162a2fe004ab4e09de5e037be7553 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Neural|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.94e-06 | 162 | 68 | 5 | e35ddce830e20ebeac1a2c405293fc4a5323dd4a | |
| ToppCell | LV-16._Neuronal|World / Chamber and Cluster_Paper | 5.40e-06 | 165 | 68 | 5 | 6ed52cb756d21addf46c7f6c457458b01339fe04 | |
| ToppCell | facs-Heart-RA-18m-Lymphocytic-B_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.56e-06 | 166 | 68 | 5 | fc2cf67311c86fda75b35fcd4768b6f6f14c59d0 | |
| ToppCell | facs-Heart-RA-18m-Lymphocytic-B_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.56e-06 | 166 | 68 | 5 | 33a6876d06e26176135a73a77c19e634ec53f7ce | |
| ToppCell | COVID-19-Heart-Neuronal|Heart / Disease (COVID-19 only), tissue and cell type | 6.80e-06 | 173 | 68 | 5 | 6fb5f9e6536a5d57fd8e6657b494047a2d0bc9c7 | |
| ToppCell | facs-Trachea-18m-Mesenchymal-fibroblast-fibroblast_of_trachea-tracheal_fibroblast_l20-1|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.99e-06 | 174 | 68 | 5 | 1d157f7a919c8246e83d8060d2a0017c6c781ef3 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 7.39e-06 | 176 | 68 | 5 | 9bc87cd5cda2372e1bce94c9dfd408eb1dfd8d0c | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 7.39e-06 | 176 | 68 | 5 | 3f8274a7ab67f9f8a8923193763a5543cfe4defa | |
| ToppCell | wk_15-18-Epithelial-PNS-intermediate_Schwann|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 8.93e-06 | 183 | 68 | 5 | d874aa9a856f79626c8a8371f6196a77b7d662ee | |
| ToppCell | E17.5-Mesenchymal-mesenchymal_fibroblast-mesenchymal_alveolar_niche_cell|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 9.41e-06 | 185 | 68 | 5 | c85bba1210f1d389add3e40be9b96abac40cf8c1 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.02e-05 | 188 | 68 | 5 | b21e93a70583c30d05c0833cd3d4d4bca44a039e | |
| ToppCell | facs-Trachea-3m-Mesenchymal-fibroblast-fibroblast_of_trachea-tracheal_fibroblast_l20-1|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.02e-05 | 188 | 68 | 5 | aa516273cdde53c8c0295f06830972388f890c97 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.02e-05 | 188 | 68 | 5 | 874404a4fd9aa42873f6c53dc42da22d3b0fdb9e | |
| ToppCell | (2)_Fibroblasts-(22)_Fibro-3|World / Cell class and subclass of bone marrow stroma cells in homeostatis | 1.07e-05 | 190 | 68 | 5 | 3aed03b87ba2c8d479048c3ceef3ff5e38746c28 | |
| ToppCell | E15.5-Mesenchymal-mesenchymal_fibroblast-mesenchymal_alveolar_niche_cell|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.10e-05 | 191 | 68 | 5 | 053b3664f509baa107feaf90730f80ebf9ac8f14 | |
| ToppCell | facs-Trachea-3m-Mesenchymal-fibroblast-fibroblast_of_trachea-tracheal_fibroblast_l20-25|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.13e-05 | 192 | 68 | 5 | 30cefa0990ba1f379f350bfbf994a78db145075e | |
| ToppCell | facs-Trachea-18m-Mesenchymal-fibroblast-fibroblast_of_trachea-tracheal_fibroblast_l20-25|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.18e-05 | 194 | 68 | 5 | 7b6ec45adb7ece3c8a7b78c5782413b5825effe2 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Neuronal-Glial_mature-Adult_Glia|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.18e-05 | 194 | 68 | 5 | d429bb5e422a07bd92f0dc48cd51528e8b7d9a72 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid_mast-Myeloid_Mast/Baso-mast_cell-Mast_cells-Mast_cells_L.1.4.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.18e-05 | 194 | 68 | 5 | a85e98af9dc9a4f0437be3700d63a6d21415199b | |
| ToppCell | PND03-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.18e-05 | 194 | 68 | 5 | 44c7d4b75f3b7c9301eba20610e548a01a84ae40 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Neuronal|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.18e-05 | 194 | 68 | 5 | bffdf6db0bf3fb338e7bb0789ae7dcde1fce0094 | |
| ToppCell | PND03-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1-CAP1_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.18e-05 | 194 | 68 | 5 | 7f24023df47935286f185dd428d48797daf26f49 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Neuronal-Glial_mature|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.18e-05 | 194 | 68 | 5 | 408dfc7060095972a54ae37ae8105521df6fbbee | |
| ToppCell | TCGA-Head_and_Esophagus-Primary_Tumor-Head_and_Neck_Carcinoma-Squamous_Cell_Carcinoma-8|TCGA-Head_and_Esophagus / Sample_Type by Project: Shred V9 | 1.18e-05 | 194 | 68 | 5 | 55b97095a7a17a312c616703d291738a0f806339 | |
| ToppCell | PCW_05-06-Mesenchymal|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.24e-05 | 196 | 68 | 5 | dca52c57ba35d9395cdbca8b881f12ece721b10f | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.24e-05 | 196 | 68 | 5 | fa445f4240c521cf04eb2e2f79a5c55fda31209a | |
| ToppCell | Epithelial_cells-AT1_cells|Epithelial_cells / lung cells shred on cell class, cell subclass, sample id | 1.24e-05 | 196 | 68 | 5 | 6c99d29162848161c1f166a032320f87a5d5a631 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.24e-05 | 196 | 68 | 5 | 802f61e78a9a1030a86c4a980c398a73cd4d1574 | |
| ToppCell | facs-Trachea-24m-Mesenchymal-fibroblast-fibroblast_of_trachea-tracheal_fibroblast_l20-25|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.24e-05 | 196 | 68 | 5 | ed6047b48b6a96baa6a90c7af784e7c34b32824d | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-1_mon-Neuronal-Subcortical|1_mon / Sample Type, Dataset, Time_group, and Cell type. | 1.24e-05 | 196 | 68 | 5 | bf8fe28193348342987d361c8e8b9e1d6d542678 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Myeloid-Macrophage-macrophage,_alveolar-Macro_c1-C1QC|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.27e-05 | 197 | 68 | 5 | 1ded28732ea5d1f9ebca0b136575103540600ff1 | |
| ToppCell | (2)_Fibroblasts-(22)_Fibro-3|(2)_Fibroblasts / Cell class and subclass of bone marrow stroma cells in homeostatis | 1.27e-05 | 197 | 68 | 5 | d9021bab82403e566ec10f78acb227c0f80b88fe | |
| ToppCell | CD8+_Memory_T_cell-CV-3|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster | 1.27e-05 | 197 | 68 | 5 | 9fe3d53346a95c1bbb0fc6a2f2e974889873424b | |
| ToppCell | Tracheal-10x5prime-Stromal-Schwann-Schwann_nonmyelinating|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.27e-05 | 197 | 68 | 5 | e239caae24f40564a24ad909754f5436f767ccdb | |
| ToppCell | CV-Moderate-3|CV / Virus stimulation, Condition and Cluster | 1.27e-05 | 197 | 68 | 5 | 7031286e300eaccf73b927939f8de3a9d2d5fc74 | |
| ToppCell | IPF-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | 1.27e-05 | 197 | 68 | 5 | f304d42fc4936fe20996e07c8dccc698a6e5e5ef | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Myeloid-Macrophage-macrophage,_alveolar-Macro_c1-C1QC|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.31e-05 | 198 | 68 | 5 | 579a22199643440b98e381147779ced630d4ed66 | |
| ToppCell | COVID-19-lung-Fibroblast|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.31e-05 | 198 | 68 | 5 | 3ec01a55ade5e1627258cc3cfebb2c3207a4cb43 | |
| ToppCell | Macrophages-IPF_03|World / lung cells shred on cell class, cell subclass, sample id | 1.31e-05 | 198 | 68 | 5 | 8517386a2f0d14c7d5fc6283e4e16b94d7c5732a | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-2M-Neuronal-cortical_neurons_1|Organoid-2M / Sample Type, Dataset, Time_group, and Cell type. | 1.31e-05 | 198 | 68 | 5 | d81f35c0066558ff96dd06f58fca72cd82e681e8 | |
| ToppCell | Epithelial_cells-AT1-AT2_cells|Epithelial_cells / lung cells shred on cell class, cell subclass, sample id | 1.31e-05 | 198 | 68 | 5 | fbc46b20bcd44f2083170aacbc6f5dd00fba685c | |
| ToppCell | distal-Hematologic-Alveolar_Macrophage-3|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.34e-05 | 199 | 68 | 5 | 2918967da22602404c767d948fed6c4754e53518 | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.34e-05 | 199 | 68 | 5 | a7dd94b172c973a131a6792f8ccd9bfe44d984ac | |
| ToppCell | Bronchus_Control_(B.)-Stromal-TX-Fibroblasts-2,_SCARA5|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 1.37e-05 | 200 | 68 | 5 | 2022df85df94ab8cbb4e80e3fe9894c01051c5e0 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Myeloid-Macrophage|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.37e-05 | 200 | 68 | 5 | 26df6ac63710655604888c3be6509b6c4befc0be | |
| ToppCell | Lung_Parenchyma-Severe-Mesenchymal-Mesenchymal-Fibroblasts-4-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.37e-05 | 200 | 68 | 5 | 4dbe21cb63569f28c7017cda065ea5ee00d7254e | |
| ToppCell | Parenchyma_COVID-19-Stromal-TX-Fibroblasts-4|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 1.37e-05 | 200 | 68 | 5 | bde938e5a18844fb8cc1d1be5a086809f7e2b97d | |
| ToppCell | Lung_Parenchyma-Severe-Mesenchymal-Mesenchymal-Fibroblasts-4|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.37e-05 | 200 | 68 | 5 | 8256511b099c3eab8e33194f90c9ff354e7cfe8e | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.37e-05 | 200 | 68 | 5 | 34f52003988ce6329d8deeee1ab875fa77e01e9d | |
| ToppCell | LPS_only-Endothelial-Endothelial-Artery|LPS_only / Treatment groups by lineage, cell group, cell type | 1.37e-05 | 200 | 68 | 5 | b17eb1587ca86c3d40515128a00a8d8fd787fccf | |
| ToppCell | Parenchymal-10x5prime-Stromal-Fibroblastic-Fibro_myofibroblast|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.37e-05 | 200 | 68 | 5 | 54806080b5e97859ee6a4a9b4f19e22021c218f5 | |
| ToppCell | Biopsy_IPF-Mesenchymal-HAS1_High_Fibroblasts|Biopsy_IPF / Sample group, Lineage and Cell type | 1.37e-05 | 200 | 68 | 5 | d02e256b5d65a5c982ba5696bc7e077281ca3e24 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Myeloid-Macrophage-macrophage,_alveolar|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.37e-05 | 200 | 68 | 5 | 07819a90ac347883b78d0bb3cd8c5eb0d66e1e22 | |
| ToppCell | Control-Neutrophil|Control / Disease condition and Cell class | 4.16e-05 | 126 | 68 | 4 | 450c01d89714feee6529680ec3ce69067a54b37c | |
| ToppCell | Control-Neutrophil-|Control / Disease condition and Cell class | 4.16e-05 | 126 | 68 | 4 | 65fff5ec2296272e94f44546606587833191dd82 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.76e-05 | 137 | 68 | 4 | 85b3a98039c1f68addad0334aa5b2584f6045aaa | |
| ToppCell | COVID-19-kidney-Technical/muscle_(PCT)|kidney / Disease (COVID-19 only), tissue and cell type | 7.37e-05 | 146 | 68 | 4 | c55f1bdb6ac43b4118cb27ea7c879527e1afcbab | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Tshz2-Excitatory_Neuron.Slc17a7-Slc17a6.Tshz2-Rasd1_(Presubiculum,_Col5a2+)-|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 7.75e-05 | 54 | 68 | 3 | e40294b708b06f7eee1c099fc67f53a3bb76e306 | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Tshz2-Excitatory_Neuron.Slc17a7-Slc17a6.Tshz2-Rasd1_(Presubiculum,_Col5a2+)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 7.75e-05 | 54 | 68 | 3 | a1b3f38a90ca975a3e9c4dadfe3cd4e701a6cb1e | |
| ToppCell | facs-Marrow-T-cells-3m-Myeloid-granulocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.77e-05 | 148 | 68 | 4 | b4632029ebd14969bda59a1bd1454eadb8efe563 | |
| ToppCell | facs-Marrow-T-cells-3m-Myeloid-granulocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.77e-05 | 148 | 68 | 4 | ba277c898678dd36f8dc1d681301c71901b89055 | |
| ToppCell | Hippocampus-Hematopoietic|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 8.40e-05 | 151 | 68 | 4 | 81b2189afd72658f7e2539b856ba79cd49340215 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-OPC-OPC-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 9.30e-05 | 155 | 68 | 4 | 77fdae85d36efb776db977eb424b32487ef222e4 | |
| ToppCell | PND14-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_B-B-B_prolif|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.53e-05 | 156 | 68 | 4 | 6f8622716bad4e505f241a2a4ef953bf3fc6dbfa | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.53e-05 | 156 | 68 | 4 | dd41ed918b07fa248da458a629b3c53cb7ea8764 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.53e-05 | 156 | 68 | 4 | abf9dd075b1ca8f613c660cc82f8a5af071fb6ab | |
| ToppCell | facs-Lung-24m-Hematologic-myeloid-neutrophil|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.77e-05 | 157 | 68 | 4 | e96241db2b5ff52b230e3e33207e7bb968900cab | |
| ToppCell | PND03-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1-CAP1_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.77e-05 | 157 | 68 | 4 | 2c946c6ab284fac3c25db688ed0aabe5a3f9ffa5 | |
| ToppCell | droplet-Heart-HEART_(LV+RV_ONLY)-30m-Myeloid-mast_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.77e-05 | 157 | 68 | 4 | cca7f23485b9d1a1c96134b6ca85dc7dba0c0522 | |
| ToppCell | droplet-Heart-HEART_(LV+RV_ONLY)-30m-Myeloid|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.77e-05 | 157 | 68 | 4 | 241c983fc3fc5c98113baf27e03ff0eede611bd8 | |
| ToppCell | facs-Lung-24m-Hematologic-myeloid-neutrophil-neutrophil|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.77e-05 | 157 | 68 | 4 | 07a0f8d29a3111be670eae030a91474465eba734 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Mes)|kidney / Disease (COVID-19 only), tissue and cell type | 1.03e-04 | 159 | 68 | 4 | 5335cbcdeaf2bbd0268bbfe0e45c8c0d288e640d | |
| ToppCell | Frontal_cortex-Hematopoietic-MICROGLIA|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 1.03e-04 | 159 | 68 | 4 | 41d2c1e71f6983156f8cc8ec5f69e025e5700f46 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Lymphocytic-T_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.05e-04 | 160 | 68 | 4 | 97c899df1b57fd2bd1867e02bfedf1920c00ad17 | |
| ToppCell | PND10-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-Treg-Treg_prolif|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.05e-04 | 160 | 68 | 4 | ec81814f3a475ba9bc049cb793bf93bc0b650d37 | |
| ToppCell | facs-Lung-Endomucin_-18m-Myeloid-Neutrophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.08e-04 | 161 | 68 | 4 | e227f7b711475624cf80e77f235b1783d88d57b4 | |
| ToppCell | droplet-Lung-3m-Hematologic-lymphocytic-Zbtb32+_B_cell-Zbtb32+_B_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.08e-04 | 161 | 68 | 4 | 7af3b0d4fc7967f6b3e2d255d23fd8b1fd01a7af | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Neural-neural_cell-Schwann_Cell_/_Neural|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.08e-04 | 161 | 68 | 4 | 7d1bc73f4c82465b3f489d6737048b0cd54f22cf | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Neural-neural_cell-Schwann_Cell_/_Neural-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.08e-04 | 161 | 68 | 4 | 410eef62c83c704cbfc5a1b643c4db11bbdcd81f | |
| ToppCell | facs-Lung-Endomucin_-18m-Myeloid-neutrophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.08e-04 | 161 | 68 | 4 | 8280a029026c272cae9649b27575831b0dd4e242 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Neural|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.08e-04 | 161 | 68 | 4 | 71022485da6754a2b57b4c3e758e3de4c95cc292 | |
| ToppCell | droplet-Lung-3m-Hematologic-lymphocytic-Zbtb32+_B_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.08e-04 | 161 | 68 | 4 | 98be0cf8228496b31f7f3e0efd8787e95eb626d1 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Neural-neural_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.08e-04 | 161 | 68 | 4 | 59ae8a7c9a04ecaa335b8064852a5a91a21780bd | |
| ToppCell | facs-Trachea-24m-Mesenchymal-fibroblast-fibroblast_of_trachea-tracheal_fibroblast_l20-1|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.10e-04 | 162 | 68 | 4 | 56f1789e69a6cb29956e46aba92b290847327c1f | |
| ToppCell | 10x5'-Liver-Lymphocytic_Invariant-Inducer-like-ILC3|Liver / Manually curated celltypes from each tissue | 1.13e-04 | 163 | 68 | 4 | 7f61483eeb1fde21843c6391468e13cb0cc2a89f | |
| Computational | Testis genes. | 1.50e-04 | 310 | 41 | 7 | MODULE_72 | |
| Drug | 201 Tl | 2.55e-05 | 3 | 67 | 2 | CID000072170 | |
| Drug | (-)-MK 801 hydrogen maleate [77086-19-2]; Up 200; 11.8uM; MCF7; HT_HG-U133A | 2.57e-05 | 198 | 67 | 6 | 6458_UP | |
| Drug | Chlorthalidone [77-36-1]; Up 200; 11.8uM; MCF7; HT_HG-U133A | 2.57e-05 | 198 | 67 | 6 | 6800_UP | |
| Drug | Furosemide [54-31-9]; Up 200; 12uM; MCF7; HT_HG-U133A | 2.57e-05 | 198 | 67 | 6 | 3197_UP | |
| Drug | Alfuzosin hydrochloride [81403-68-1]; Up 200; 9.4uM; MCF7; HT_HG-U133A | 2.65e-05 | 199 | 67 | 6 | 3203_UP | |
| Drug | Amiloride hydrochloride dihydrate [17440-83-4]; Up 200; 13.2uM; MCF7; HT_HG-U133A | 2.72e-05 | 200 | 67 | 6 | 4109_UP | |
| Drug | CP-944629 [668990-94-1]; Down 200; 10uM; MCF7; HT_HG-U133A | 2.72e-05 | 200 | 67 | 6 | 7544_DN | |
| Disease | Crohn's disease of large bowel | 3.08e-06 | 44 | 67 | 4 | C0156147 | |
| Disease | IIeocolitis | 3.08e-06 | 44 | 67 | 4 | C0949272 | |
| Disease | Crohn's disease of the ileum | 3.08e-06 | 44 | 67 | 4 | C0267380 | |
| Disease | Regional enteritis | 3.08e-06 | 44 | 67 | 4 | C0678202 | |
| Disease | Crohn Disease | 5.17e-06 | 50 | 67 | 4 | C0010346 | |
| Disease | autoimmune thyroid disease, systemic lupus erythematosus, type 1 diabetes mellitus, ankylosing spondylitis, psoriasis, common variable immunodeficiency, celiac disease, ulcerative colitis, Crohn's disease, autoimmune disease, juvenile idiopathic arthritis | 1.99e-05 | 70 | 67 | 4 | EFO_0000384, EFO_0000676, EFO_0000729, EFO_0001060, EFO_0002609, EFO_0003898, EFO_0005140, EFO_0006812, MONDO_0005147, MONDO_0007915, MONDO_0015517 | |
| Disease | psoriasis, type 2 diabetes mellitus | 2.61e-05 | 75 | 67 | 4 | EFO_0000676, MONDO_0005148 | |
| Disease | respiratory failure, COVID-19 | 3.92e-05 | 29 | 67 | 3 | EFO_0009686, MONDO_0100096 | |
| Disease | Graves' disease (is_implicated_in) | 9.64e-05 | 39 | 67 | 3 | DOID:12361 (is_implicated_in) | |
| Disease | longitudinal alcohol consumption measurement | 1.81e-04 | 9 | 67 | 2 | EFO_0007645 | |
| Disease | Colorectal Carcinoma | 1.87e-04 | 702 | 67 | 8 | C0009402 | |
| Disease | primary biliary cirrhosis | 2.43e-04 | 133 | 67 | 4 | EFO_1001486 | |
| Disease | Ankylosing spondylitis | 2.76e-04 | 11 | 67 | 2 | C0038013 | |
| Disease | Paranoia | 2.76e-04 | 11 | 67 | 2 | C1456784 | |
| Disease | Psoriasis | 3.00e-04 | 57 | 67 | 3 | C0033860 | |
| Disease | Pustulosis of Palms and Soles | 3.00e-04 | 57 | 67 | 3 | C0030246 | |
| Disease | psoriasis vulgaris | 3.66e-04 | 61 | 67 | 3 | EFO_1001494 | |
| Disease | sarcoidosis | 4.22e-04 | 64 | 67 | 3 | MONDO_0019338 | |
| Disease | Colorectal Neoplasms | 4.22e-04 | 277 | 67 | 5 | C0009404 | |
| Disease | urate measurement, bone density | 5.06e-04 | 619 | 67 | 7 | EFO_0003923, EFO_0004531 | |
| Disease | testosterone measurement | 5.77e-04 | 1275 | 67 | 10 | EFO_0004908 | |
| Disease | behavioural disinhibition measurement | 6.72e-04 | 75 | 67 | 3 | EFO_0006946 | |
| Disease | COVID-19, osteoarthritis | 9.40e-04 | 20 | 67 | 2 | MONDO_0005178, MONDO_0100096 | |
| Disease | psoriatic arthritis | 1.03e-03 | 87 | 67 | 3 | EFO_0003778 | |
| Disease | rheumatoid arthritis, ulcerative colitis | 1.04e-03 | 21 | 67 | 2 | EFO_0000685, EFO_0000729 | |
| Disease | Behcet Syndrome | 1.36e-03 | 24 | 67 | 2 | C0004943 | |
| Disease | ICAM-1 measurement | 1.36e-03 | 24 | 67 | 2 | EFO_0004520 | |
| Disease | Breast Carcinoma | 1.39e-03 | 538 | 67 | 6 | C0678222 | |
| Disease | Vitiligo | 1.59e-03 | 101 | 67 | 3 | EFO_0004208 | |
| Disease | anogenital venereal wart (is_marker_for) | 1.59e-03 | 26 | 67 | 2 | DOID:11168 (is_marker_for) | |
| Disease | malaria | 1.64e-03 | 102 | 67 | 3 | EFO_0001068 | |
| Disease | neuroticism measurement, cognitive function measurement | 1.80e-03 | 566 | 67 | 6 | EFO_0007660, EFO_0008354 | |
| Disease | biological sex | 1.88e-03 | 230 | 67 | 4 | PATO_0000047 | |
| Disease | hepatocellular carcinoma (biomarker_via_orthology) | 1.93e-03 | 108 | 67 | 3 | DOID:684 (biomarker_via_orthology) | |
| Disease | Early Pregnancy Loss | 1.98e-03 | 109 | 67 | 3 | C3830362 | |
| Disease | Spontaneous abortion | 1.98e-03 | 109 | 67 | 3 | C0000786 | |
| Disease | Miscarriage | 1.98e-03 | 109 | 67 | 3 | C4552766 | |
| Disease | Abortion, Tubal | 1.98e-03 | 109 | 67 | 3 | C0000822 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| QPESVSTSDEGYYDS | 376 | Q8N944 | |
| DSEDAYPYVGQEESC | 196 | P43235 | |
| YVEPENVTIQCDSGY | 501 | P04003 | |
| CSSYIDSYDPSTGEV | 21 | Q9H2A2 | |
| TVEYGEDLPECVQVY | 1061 | P26358 | |
| EGYIPSNYVTEAEDS | 261 | Q06187 | |
| EDAETFYDNSTTPYC | 341 | O95477 | |
| TFSECSYPETEEEGE | 231 | P78524 | |
| YGSSVCEPDDESGYD | 1601 | Q6W2J9 | |
| QTDPYSAEYVVCQDS | 201 | Q7Z4T9 | |
| LYGQSVEDDYCISPS | 21 | Q9Y450 | |
| EQPAGACEYSYCEDE | 471 | Q8IY17 | |
| EDTSTPGVPTCYYDT | 936 | Q2M2H8 | |
| EIQNVDVYDEGPYTC | 101 | Q9P121 | |
| DVYDEGPYTCSVQTD | 106 | Q9P121 | |
| IISSYPDDESVYCTT | 66 | Q8TD10 | |
| QGYPCEEYEVATEDG | 56 | Q5VYY2 | |
| AVAVYSYSCEGPEEE | 241 | Q9C0B1 | |
| PYSYDQEVAEVEAAT | 196 | P98095 | |
| VDSVEEGDLGNYSCY | 321 | Q9NZN1 | |
| GSEECVFYTDETASP | 611 | Q765P7 | |
| ANEPTYFTVDCSEAG | 781 | Q14315 | |
| DSGEYLCNISSDEYT | 311 | Q9UM44 | |
| TQCIPEGLESYYAEQ | 121 | P42857 | |
| ESCTITAYPCDSYQD | 261 | Q8WWY8 | |
| EYEYSVECQEDSACP | 186 | P29460 | |
| NQYYTTGVCSDISPD | 141 | P17301 | |
| EEPYYDCHECTETFT | 1501 | Q9GZU2 | |
| YEYDVRTTDICAGPE | 401 | Q9UHF4 | |
| TYTCDQCGAETYQPI | 181 | P33993 | |
| ESYEDGCEDYPTLSE | 146 | Q9H074 | |
| ASVTPYDNGEYICVA | 1326 | Q96RW7 | |
| IYGTVNEDAGDYTCV | 4406 | Q96RW7 | |
| GISYDSPDYTDESCT | 26 | P48551 | |
| DVYDEGPYTCSVQTD | 106 | Q14982 | |
| DGSYVNLYDSCVDDT | 301 | Q9NR21 | |
| YPPEYTCSSETDAQS | 251 | P81408 | |
| TEEETGVYQCEVEVY | 631 | Q93033 | |
| EYQACYGVEALTESE | 776 | Q659A1 | |
| DEEGYVPTSYVEVCL | 596 | Q96RU3 | |
| ESDYAPGEEYTCGTN | 1341 | Q13698 | |
| DTTTEFDYGDATPCQ | 11 | P32246 | |
| DPVDQCQDSETGTFY | 556 | P02751 | |
| DIPDEVTCVIYEYSG | 126 | Q5VWK5 | |
| SCEEIEYPATISYSS | 376 | Q9NY37 | |
| PEDLSYQIYDVSGES | 96 | Q71RC2 | |
| TTVDYTYFSEPVSCE | 301 | Q8IZU9 | |
| IYEACSYGSIPVVED | 341 | Q9Y2B1 | |
| YTVQSELGDYDPDEC | 231 | Q9Y2J2 | |
| GTDEDDYSCSVYTQE | 111 | Q8IZK6 | |
| APCYESDTDIYETVA | 21 | Q6PGQ1 | |
| EPYSTCGYSQSEGDD | 31 | P28827 | |
| VYPVGEDYYACTETN | 136 | Q16518 | |
| GYCYQDSEDIPDTLT | 216 | Q504Y2 | |
| VVSCEGYESSEDQYV | 111 | Q96BY9 | |
| KPDEGYYQCVATVES | 121 | Q92859 | |
| ELSSGEEYYVACDNT | 2306 | Q9UKZ4 | |
| EEYYVACDNTGTPLA | 2311 | Q9UKZ4 | |
| SYITEDDVVYRPGDC | 96 | Q9P2R6 | |
| EEPSTSGEQTYYDLV | 191 | Q07889 | |
| SPDNVCYEGQSAYDV | 626 | Q92502 | |
| ECTSAVSVDVEGYIY | 596 | P28288 | |
| CYEATDTETGSAYAV | 76 | Q9H4B4 | |
| IYGEVYAGEIDVCSS | 1021 | Q9BX84 | |
| PDYYTEVVEQSLGTC | 511 | Q0IIM8 | |
| EATEEALGTYTCVPY | 386 | Q9UPX0 | |
| EAVVSVGYEYESCLD | 1076 | Q9P273 | |
| PYSVTNCGEHDTTEY | 376 | P29350 | |
| TISPVQPEDDADYYC | 101 | Q9UKI3 | |
| FVPSCTTEGSYEDVQ | 616 | P01266 | |
| SGDYVSCDDPEVEDY | 276 | Q6EMB2 | |
| VSLYCYDPTNDGTGE | 911 | P29597 |